COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.
Stay current on PCCA news and events, market trends, and all things compounding!
Matt Martin, PharmD, BCSCP, PCCA Director of Clinical Services, reviews USP 797 revisions and impacts on compounding pharmacies in the third of a four-part series.
Matt Martin writes to help compounding pharmacies navigate the Food and Drug Administration’s (FDA’s) recently finalized guidance document Insanitary Conditions at Compounding Facilities.